Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

biotest pharma gmbh - normalt immunglobulin, humant - infusionsvæske, opløsning - 50 g/l

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

octapharma ab - normalt immunglobulin, humant - infusionsvæske, opløsning - 50 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

octapharma ab - anti-d immunglobulin, humant - injektionsvæske, opløsning - 625 ie/ml

Den Europæiske Union - dansk - EMA (European Medicines Agency)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - immune sera og immunoglobuliner, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - immune sera og immunoglobuliner, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

roche registration gmbh  - casirivimab, imdevimab - covid-19 virus infection - immune sera og immunoglobuliner, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. se afsnit 4. 4 og 5.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - immune sera og immunoglobuliner, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

astrazeneca ab - nirsevimab - immune sera og immunoglobuliner, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

instituto grifols s.a. - normalt immunoglobulin til intravenøs brug, humant - injektionsvæske, opløsning - 200 mg/ml

Den Europæiske Union - dansk - EMA (European Medicines Agency)

biotest pharma gmbh - human hepatitis b immunoglobulin - immunization, passive; hepatitis b; liver transplantation - immune sera og immunoglobuliner, - forebyggelse af hepatitis b virus (hbv) re-infektion hos hbsag og hbv-dna-negative voksne patienter mindst en uge efter levertransplantation for hepatitis b induceret leversvigt. hbv-dna-negativ status bør bekræftes inden for de sidste 3 måneder før olt. patienterne bør være hbsag-negative før behandlingen starter. samtidig brug af passende virostatic agenter bør betragtes som standard for hepatitis b re-infektion profylakse.